Abstract

We appreciate the interest of Cohen et al. (2014) in our recent research on inorganic arsenic carcinogenesis in mice after whole-life exposure (Waalkes et al., 2014). However, we strongly disagree with their conclusion that this study does not show an arsenic-related lung tumor response because of comparison to historical controls in CD1 mice (Cohen et al., 2014). Cohen et al. (2014) assert this lack of an association despite the facts that our study includes fully satisfactory concurrent male and female control groups that show lung tumor rates equivalent to historical controls and that specific treatment groups show robust differences in lung tumor incidences when compared in a statistically appropriate fashion to these concurrent controls.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.